Summary
156.82 -0.08(-0.05%)07/14/2025
Johnson & Johnson (JNJ)
JNJ reported last earnings on 2025-04-15 after the market. An EPS of $2.77 was observed compared to an estimated EPS of $2.58, resulting in a surprise value of $0.19. A revenue of $21,893 million was observed compared to an estimated revenue of $21,559 million, resulting in a surprise value of $334 Million.
Johnson & Johnson (JNJ)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| -0.87 | 0.66 | 0.00 | 2.46 | 10.14 | 8.50 | 21.91 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B+ |
| Recommended Rating | Neutral |
| DCF | Buy |
| ROE | Strong Buy |
| ROA | Strong Buy |
| Debt/Equity | Strong Sell |
| P/E | Sell |
| P/B | Sell |
Earnings
| Trading Data | ||
| Close | 155.46 | |
| Open | 156.36 | |
| High | 157.14 | |
| Low | 154.69 | |
| Volume | 3,955,056 | |
| Change | -1.36 | |
| Change % | -0.87 | |
| Avg Volume (20 Days) | 8,239,733 | |
| Volume/Avg Volume (20 Days) Ratio | 0.48 | |
| 52 Week Range | 138.69 - 168.54 | |
| Price vs 52 Week High | -7.76% | |
| Price vs 52 Week Low | 12.09% | |
| Range | 0.00 | |
| Gap Up/Down | -0.31 | |
Profitibility | ||
| Market Capitalization (Mln) | 373,735 | |
| Revenue per share | 37.1342 | |
| Net Income per share | 9.0663 | |
| Dividend Yield | 0.0320 | |
| Dividend Share | 502.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 17.2971 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
07/15 05:08 EST - fool.com
10 Dividend Stocks to Double Up On Right Now
Dividend stocks can make great long-term investments. They've outperformed nonpayers by more than 2-to-1 over the past 50 years, with a 9.2% average annual return compared with 4.3%, according to data from Hartford Funds and Ned Davis Research.
10 Dividend Stocks to Double Up On Right Now
Dividend stocks can make great long-term investments. They've outperformed nonpayers by more than 2-to-1 over the past 50 years, with a 9.2% average annual return compared with 4.3%, according to data from Hartford Funds and Ned Davis Research.
07/15 03:00 EST - fool.com
Should You Buy Johnson & Johnson Stock Before July 16th?
Johnson & Johnson (JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion. Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse...
Should You Buy Johnson & Johnson Stock Before July 16th?
Johnson & Johnson (JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion. Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse...
07/14 17:09 EST - marketbeat.com
These 3 Undervalued Stocks Could Surge as Value Rotation Nears
One of the most reliable gauges of sentiment in the stock market is where growth stocks trade relative to value stocks, since any given extreme can signal above-average optimism or pessimism, creating opportunities for investors to ride a return to balance. Toda's market appears to be driven by...
These 3 Undervalued Stocks Could Surge as Value Rotation Nears
One of the most reliable gauges of sentiment in the stock market is where growth stocks trade relative to value stocks, since any given extreme can signal above-average optimism or pessimism, creating opportunities for investors to ride a return to balance. Toda's market appears to be driven by...
07/14 12:05 EST - zacks.com
Pre-Markets in the Red to Start a Fresh Week
Pre-market futures are notably lower than Friday afternoon's close on all major indexes, though they are beginning to climb out of the muck of fresh tariff threats as early trading warms up to start a new trading week. We had gotten back up to or near record market highs last week before new tariff...
Pre-Markets in the Red to Start a Fresh Week
Pre-market futures are notably lower than Friday afternoon's close on all major indexes, though they are beginning to climb out of the muck of fresh tariff threats as early trading warms up to start a new trading week. We had gotten back up to or near record market highs last week before new tariff...
07/14 11:54 EST - fool.com
Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit
On July 11, 2025, Andrew Hill Investment Advisors, Inc. disclosed it sold out its entire Johnson & Johnson (JNJ -0.63%) position, totaling $6.31 million in trades.
Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit
On July 11, 2025, Andrew Hill Investment Advisors, Inc. disclosed it sold out its entire Johnson & Johnson (JNJ -0.63%) position, totaling $6.31 million in trades.
07/14 10:21 EST - zacks.com
Should J&J Stock Be in Your Portfolio Ahead of Q2 Earnings?
JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.
Should J&J Stock Be in Your Portfolio Ahead of Q2 Earnings?
JNJ eyes Q2 growth with strong drug sales and new launches, but Stelara biosimilars and MedTech headwinds loom.
07/14 10:05 EST - forbes.com
Johnson & Johnson: Buy JNJ Stock Ahead of Its Upcoming Earnings?
Johnson & Johnson (NYSE:JNJ) is set to report its earnings on Wednesday, July 16, 2025. For traders focused on events, analyzing historical stock behavior surrounding earnings reports can be an important strategy, possibly improving the odds in your favor.
Johnson & Johnson: Buy JNJ Stock Ahead of Its Upcoming Earnings?
Johnson & Johnson (NYSE:JNJ) is set to report its earnings on Wednesday, July 16, 2025. For traders focused on events, analyzing historical stock behavior surrounding earnings reports can be an important strategy, possibly improving the odds in your favor.
07/13 14:00 EST - barrons.com
Wells Fargo, Citi, Netflix, J&J, and More Stocks to Watch This Week
Financials make up half of the 38 S&P 500 companies slated to report quarterly results this week. The week's big economic news will be the consumer price index for June.
Wells Fargo, Citi, Netflix, J&J, and More Stocks to Watch This Week
Financials make up half of the 38 S&P 500 companies slated to report quarterly results this week. The week's big economic news will be the consumer price index for June.
07/13 05:12 EST - fool.com
This Stock Has Increased 4,720%: Here's Why It's Still a Buy
Time is one of investors' greatest allies. With enough patience, even a relatively small sum of money invested in an excellent company can yield substantial returns, especially when dividends are reinvested.
This Stock Has Increased 4,720%: Here's Why It's Still a Buy
Time is one of investors' greatest allies. With enough patience, even a relatively small sum of money invested in an excellent company can yield substantial returns, especially when dividends are reinvested.
07/11 12:10 EST - zacks.com
Pre-Markets Red on Trump's Tariff Threats to Canada
Pre-Markets Red on Trump's Tariff Threats to Canada.
Pre-Markets Red on Trump's Tariff Threats to Canada
Pre-Markets Red on Trump's Tariff Threats to Canada.
07/11 12:01 EST - seekingalpha.com
Mar Vista U.S. Quality Q2 2025 Top Contributors And Detractors
Microsoft, Broadcom, and Oracle were among the portfolio's top contributors for the quarter. Alternatively, Apple, Johnson & Johnson, and Berkshire Hathaway detracted from performance. Microsoft shares rebounded in calendar Q2 following a strong fiscal Q3 2025 (March quarter), driven by...
Mar Vista U.S. Quality Q2 2025 Top Contributors And Detractors
Microsoft, Broadcom, and Oracle were among the portfolio's top contributors for the quarter. Alternatively, Apple, Johnson & Johnson, and Berkshire Hathaway detracted from performance. Microsoft shares rebounded in calendar Q2 following a strong fiscal Q3 2025 (March quarter), driven by...
07/11 10:16 EST - zacks.com
Unveiling Johnson & Johnson (JNJ) Q2 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Johnson & Johnson (JNJ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Unveiling Johnson & Johnson (JNJ) Q2 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Johnson & Johnson (JNJ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
07/11 09:01 EST - zacks.com
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
07/11 03:55 EST - fool.com
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
Dividend investing, like most things in life, can be rewarding if done correctly or a headache if you make crucial mistakes. The key to dividend investing is to pick the right types of dividend stocks.
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
Dividend investing, like most things in life, can be rewarding if done correctly or a headache if you make crucial mistakes. The key to dividend investing is to pick the right types of dividend stocks.
07/11 03:41 EST - benzinga.com
Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Johnson & Johnson JNJ will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.
Johnson & Johnson Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Johnson & Johnson JNJ will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.
07/11 03:10 EST - fool.com
2 Dividend Stocks to Double Up on Right Now
No matter what the market is doing, one specific type of stock always will reward you -- and you don't have to lift a finger. This may sound too good to be true, but it actually isn't.
2 Dividend Stocks to Double Up on Right Now
No matter what the market is doing, one specific type of stock always will reward you -- and you don't have to lift a finger. This may sound too good to be true, but it actually isn't.
07/10 08:17 EST - seekingalpha.com
3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies
I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. Three companies—Pfizer, BMW, and Singapore Airlines—currently meet my 'IDEAL' dividend criteria, with dividends from $1K invested exceeding their single share...
3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies
I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. Three companies—Pfizer, BMW, and Singapore Airlines—currently meet my 'IDEAL' dividend criteria, with dividends from $1K invested exceeding their single share...
07/10 08:02 EST - 247wallst.com
Turn $5,000 into $300,000 with Top Dividend Stocks Like JNJ, PEP, and UPS
The majority of investors do not have hundreds of thousands of dollars to place into the stock market.
Turn $5,000 into $300,000 with Top Dividend Stocks Like JNJ, PEP, and UPS
The majority of investors do not have hundreds of thousands of dollars to place into the stock market.
07/09 14:38 EST - benzinga.com
Johnson & Johnson's Outlook Clouded By $2 Billion Headwind
Johnson & Johnson JNJ is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of $22.85 billion.
Johnson & Johnson's Outlook Clouded By $2 Billion Headwind
Johnson & Johnson JNJ is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of $22.85 billion.
07/09 13:57 EST - 247wallst.com
I Have Invested in Dividends For 15 Years—These Dividend Aristocrats Built My Passive Income Stream
These dividend aristocrats haven't disappointed me in 15 years and won't disappoint you either.
I Have Invested in Dividends For 15 Years—These Dividend Aristocrats Built My Passive Income Stream
These dividend aristocrats haven't disappointed me in 15 years and won't disappoint you either.